UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date: April 11, 2019
Form: S-1
CIK: 0001169245
Company Name: PhaseBio Pharmaceuticals Inc
File Number: 333-230783
PhaseBio Pharmaceuticals (NASDAQ:PHAS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more PhaseBio Pharmaceuticals Charts.
PhaseBio Pharmaceuticals (NASDAQ:PHAS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more PhaseBio Pharmaceuticals Charts.